Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael White

Showing results (41-50 of 585) with videos related to

Pageof 59
Sort By:
The Annals of Pharmacotherapy|September 30, 2021
Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate DrugsC Michael White
The Annals of Pharmacotherapy|October 17, 2019
Generic Drugs Not as Safe as FDA Wants You to BelieveC Michael White
Journal of Clinical Pharmacology|April 1, 2016
Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health ImplicationsC Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2019
Pharmacologic and clinical assessment of kratom: An updateC Michael White
Connecticut Medicine|November 1, 2002
Antipsychotics and QTc interval prolongationC Michael White
Journal of Clinical Pharmacology|September 5, 2002
A review of the pharmacologic and pharmacokinetic aspects of rosuvastatinC Michael White
The Annals of Pharmacotherapy|February 11, 2020
Current System of Overseeing Drug Trials in Developing Countries by the FDA Is DangerousC Michael White
Journal of the American Pharmacists Association : Japha|May 31, 2020
Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United StatesC Michael White
The Annals of Pharmacotherapy|February 2, 2022
Pharmacists Have the Stats but No Provider Status: Now May Be Our MomentC Michael White
The Annals of Pharmacotherapy|April 18, 2014
3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderC Michael White
Pageof 59

Showing results (41-50 of 585) with videos related to

Sort By:
Pageof 59
The Annals of Pharmacotherapy|September 30, 2021
Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate DrugsC Michael White
The Annals of Pharmacotherapy|October 17, 2019
Generic Drugs Not as Safe as FDA Wants You to BelieveC Michael White
Journal of Clinical Pharmacology|April 1, 2016
Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health ImplicationsC Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2019
Pharmacologic and clinical assessment of kratom: An updateC Michael White
Connecticut Medicine|November 1, 2002
Antipsychotics and QTc interval prolongationC Michael White
Journal of Clinical Pharmacology|September 5, 2002
A review of the pharmacologic and pharmacokinetic aspects of rosuvastatinC Michael White
The Annals of Pharmacotherapy|February 11, 2020
Current System of Overseeing Drug Trials in Developing Countries by the FDA Is DangerousC Michael White
Journal of the American Pharmacists Association : Japha|May 31, 2020
Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United StatesC Michael White
The Annals of Pharmacotherapy|February 2, 2022
Pharmacists Have the Stats but No Provider Status: Now May Be Our MomentC Michael White
The Annals of Pharmacotherapy|April 18, 2014
3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderC Michael White
Pageof 59